Interactive tools

ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN

Rethinking Pathogenesis and Severity Assessment in Chronic Hand Eczema

Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic

Dermatology Conferences and Meetings Calendar: December 2025

Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott

Reviewing Type 2 Inflammation Through a Different Lens

How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata

Natural Fatty Acids Offer Hair Loss Relief

Hair Relaxers Tied to Higher Risk of Non-Reproductive Cancers, According to NIH Study